Good morning, good afternoon and good evening.
He proceeds According detail provided by World Health Organization on there official website
WHO is providing technical, scientific and financial support for the rollout of sero-epidemiologic surveys across the world.
Early data from some of these studies suggest that a relatively small percentage of the population may have been infected, even in heavily affected areas – not more than 2 to 3 percent.
While antibody tests are important for knowing who has been infected, tests that find the virus are a core tool for active case finding, diagnosis, isolation and treatment.
One of WHO’s priorities is to work with partners to increase the production and equitable distribution of diagnostics to the countries that need them most.
To achieve that, WHO has worked with FIND, the Foundation for Innovative New Diagnostics, and the Clinton Health Access Initiative, to identify and validate five tests that can be manufactured in large quantities.
Working together with the Global Fund, UNICEF and Unitaid, we have now placed orders for 30 million tests over the next four months.